MATERNAL SERUM SCREEN 2; DUAL MARKER (DELFIA)
Aneuploidies are major causes of perinatal death and childhood handicap. Maternal serum screening test is an effective screening method for detection of major aneuploidies like Trisomy 21 & Trisomy 18/13 in the first trimester of pregnancy. Detection rate for Down syndrome is 60% with a false positive rate of 5% if only biochemical risk is estimated. A combination of Nuchal translucency and biochemical tests (Combined test) has detection rate of Down syndrome 82 to 87% at 5% false positive rate. Addition of absent nasal bone status can improve detection rate up to 93% at false positive rate of 2.5%.
Parameter(s) covered : 5
Report Frequency: Sample Mon through Sat by 4 PM; Report Next day
Special Instruction: Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; Number of Fetuses (Single/Twins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy. Duly filled Maternal Serum Screen requisition form (Form 11) is mandatory. Valid between 9 weeks to 13 weeks + 6 days gestation.
Price : ₹ 2400.00
Parameters
- HCG, Free Beta
- PAPP-A
- Maternal Result Attachment
- Trisomy 18/13 (Biochemical + NT)
- Trisomy 21 risk (Biochemical + NT)